Back to results
RecruitingPhase 1

A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus

NCT07160257

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

ProSciento, Inc. - Main Clinic

Chula Vista, California, United States

Contact

Amgen Call Center

866-572-6436medinfo@amgen.com
View on ClinicalTrials.gov
A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus — TrialFind